FDA Drug recall D-1314-2014
Mercaptopurine Tablets USP, 50 mg, 25 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216, NDC 0054-4581-11
- FDA Drug
- Class III
- terminated
- Published 2014-05-14
On 2014-05-14 the FDA classified a Class III recall of Mercaptopurine Tablets USP, 50 mg, 25 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216, NDC 0054-4581-11 by Boehringer Ingelheim Roxane, citing labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1314-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-04-04 |
| Published | 2014-05-14 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Boehringer Ingelheim Roxane |
| Distribution | US |
Product
Mercaptopurine Tablets USP, 50 mg, 25 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216, NDC 0054-4581-11
Reason
Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.
Identifiers
| ndc | 0054-4581-27 |
|---|---|
| ndc | 0054-4581-11 |
| code_info | Lot 261997A Exp 02/16; 262214V, 359283V Exp. 05/16 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1314-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.